Women with hypopituitarism treated with growth hormone (GH) traditionally receive estrogens for sex hormone replacement in tablet form. Oral estrogen therapy robs these patients of the therapeutic benefits of GH; however, the use of transdermal patches circumvents this problem. The wastage of GH therapy is even more pronounced with contraceptive doses of estrogen.
- Vita Birzniece
- Ken K. Y. Ho